XTAMPZA
Important Safety Information

See full Important Safety Information, including Boxed Warning on Addiction, Abuse and Misuse, and other serious risks at XtampzaER.com/PI.

Belbuca
Important Safety Information

See full Important Safety Information, including Boxed Warning on Addiction, Abuse and Misuse, and Other Serious Risks at Belbuca.com/#isi-block.

NUCYNTA ER
Important Safety Information

See full Important Safety Information, including Boxed Warning on Addiction, Abuse and Misuse, and other serious risks at Nucynta.com/erPI.

NUCYNTA
Important Safety Information

See full Important Safety Information, including Boxed Warning on Addiction, Abuse and Misuse, and other serious risks at Nucynta.com/irPI.

Effective 12/31/2022, Collegium Pharmaceutical has discontinued the sale of Elyxyb™ (celecoxib) Oral Solution. Please note that this decision was not based on any safety or effectiveness concerns. We encourage discussing alternative treatment options with your patients or healthcare provider. If you have any questions, please contact Collegium Medical Information at medinfo@collegiumpharma.com.

ELYXYB
Important Safety Information

See full Important Safety Information and Other Serious Risks at Elyxyb.com/#isi.

SYMPROIC
Important Safety Information

See full Important Safety Information and Other Serious Risks at Symproic.com/#isi.

XTAMPZA® and NUCYNTA® and BELBUCA® are registered trademarks, and ELYXYB™ is a trademark of the Collegium group of companies. SYMPROIC® is a registered trademark of Shionogi, Inc.

© 2023 Collegium Pharmaceutical, Inc. All rights reserved.